Michael Lam
Biopharmaceutical Executive | R&D, Translational Oncology, Small Molecule Discovery, Genome Editing, Cell Therapy | Team & Culture Builder
- Role
- Vice President, Head of Strategy at Sail Biomedicines
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Michael Lam
Life threatening diseases have impacted friends and family throughout my life. My drive and passion to make great medicines stems from these experiences. I have 16 years of industry experience, spanning pharma, biotech, and startups, building and leading groups specializing in gene editing, small molecule discovery and translational science. During this time, I have come to realize that success is derived from effective communication, compromise and collaboration among team members. A great team is able to overcome many challenges and many challenges there are.We all realize the importance of pairing the ideal medicine for the right patient. However, only now are there technologies that enable humanity a translational understanding of complex disease biologies. Pairing with emerging bioinformatics approaches will allow for the deployment of novel modalities for potential cures. With hard work and determination, a clearer path will emerge for the successful treatment of human disease.
Experience
Vice President, Head of Strategy
Jul 2025 — Present · Cambridge, MA, US
Shape and articulate the scientific, clinical, and corporate strategy for Sail’s targeted nanoparticle platform enabling in vivo CAR‑T through the delivery of circular Endless RNA payloads for next‑generation genetic medicines.Member of the executive leadership team reporting to the Executive Chairman & Interim CEO, leveraging 16+ years across small molecues, cell therapies & genetic medicines in pharma & , biotech to guide company and partnership strategy.Partner closely with Flagship Pioneering’s BD and Growth Co support functions.Act as a visible scientific and corporate leader representing Sail in high‑level investor and partnership discussions, translating complex R&D innovation into business value.Drive competitive, commercial, and strategic landscape assessments to guide corporate direction and enable alliances focused on next‑generation cell and genetic therapies.
Education
Baylor College of Medicine
Ph.D., Cancer Cell Biology
1999 — 2004
Massachusetts Institute of Technology
American Cancer Society Postdoctoral Fellow, MicroRNA Cancer Biology
2005 — 2009
Brandeis University
B.A., Biology
1995 — 1997
Skills
- Genomics
- Matrix Management
- Cell-Based Assay Development
- Oncology
- Lead Identification
- In Vivo Animal Model Development
- Program Management
- Drug Discovery
- Platform Development
- Target Validation
- Cell Biology
- Target Identification
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.